Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Session 1 – Advances in the Treatment of Early Stage NSCLC

Participants Clinical Case Discussion: Neoadjuvant Chemo-Immunotherapy in Resectable Stage III Non-Small Cell Lung Cancer (NSCLC)

Date

15 Nov 2024

Session

Session 1 – Advances in the Treatment of Early Stage NSCLC

Topics

Cytotoxic Therapy; Immunotherapy

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Manivannan Periasamy, UK

Resources

This content is available to ESMO members and event participants.

Login

Resources from the same session

15 Nov 2024

Introduction of Immunotherapy in the Perioperative Setting

Presenter: P. Forde, IE

Session: Session 1 – Advances in the Treatment of Early Stage NSCLC

Resources:

Slides

Webcast

15 Nov 2024

Targeted Therapy in the Perioperative Setting

Presenter: J. Remon, FR

Session: Session 1 – Advances in the Treatment of Early Stage NSCLC

Resources:

Slides

Webcast

15 Nov 2024

Immunotherapy as a Component of Definitive Radiochemotherapy for Stage III

Presenter: A. Levy, FR

Session: Session 1 – Advances in the Treatment of Early Stage NSCLC

Resources:

Webcast

15 Nov 2024

Participants Clinical Case Discussion: Complete Response to Neoadjuvant Chemo-Immunotherapy in Stage IIIA NSCLC

Presenter: Niki Gavrielatou, GR

Session: Session 1 – Advances in the Treatment of Early Stage NSCLC

Resources:

Slides

Webcast